Literature DB >> 27490589

Chronic Heart Failure.

Timothy M Hoffman1.   

Abstract

OBJECTIVES: The objectives of this review are to discuss the paradigms used to stage heart failure in children, the classification and physiologic profile of cardiomyopathies, and the acute and chronic pharmacologic management of heart failure. DATA SOURCE: MEDLINE, PubMed.
CONCLUSION: The etiology of chronic heart failure in pediatrics is vast. The paradigm of extrapolating adult clinical trials and technological advancements to treat heart failure in children has become a nonsustainable model. The field of pediatric heart failure continues to advance with more robust guideline-directed care and the imminent creation of a dynamic, contemporary international database. As the field involves a markedly heterogeneous patient population, it is imperative to use pediatric specific descriptors of disease impact. The fields of pediatric heart failure and critical care medicine will continue to evolve together as childhood specific registries, quality improvement guidelines, and research will lead to practice models eliciting optimal therapy for patients with heart failure in the intensive care setting.

Entities:  

Mesh:

Year:  2016        PMID: 27490589     DOI: 10.1097/PCC.0000000000000755

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  11 in total

1.  Diagnostic Value and Clinical Performance of Cardiac Ultrasound in Patients with Chronic Heart Failure with Hypertension.

Authors:  Punan Li; Xiaoli Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-05       Impact factor: 2.650

2.  Clinical significance of sFRP5, RBP-4 and NT-proBNP in patients with chronic heart failure.

Authors:  Yu An; Qingsong Wang; Hong Wang; Na Zhang; Fengming Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Influence of targeted motivational interviewing on self-care level and prognosis during nursing care of chronic heart failure.

Authors:  Jianfei Wu; Yilan Yu; Huan Xu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Circulating lncRNA MHRT predicts survival of patients with chronic heart failure.

Authors:  Lie Zhang; Yan-Jun Wu; Sui-Long Zhang
Journal:  J Geriatr Cardiol       Date:  2019-11       Impact factor: 3.327

5.  Aerobic exercise improves cardiac function in rats with chronic heart failure through inhibition of the long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1).

Authors:  Ling Hu; Ya-Nan Xu; Qian Wang; Mei-Jie Liu; Ping Zhang; Lan-Ting Zhao; Fang Liu; Dong-Yan Zhao; He-Nan Pei; Xing-Bao Yao; Hua-Gang Hu
Journal:  Ann Transl Med       Date:  2021-02

Review 6.  Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies.

Authors:  Chen Cai; Feng Wu; Jing He; Yaoyuan Zhang; Nengxian Shi; Xiaojie Peng; Qing Ou; Ziying Li; Xiaoqing Jiang; Jiankai Zhong; Ying Tan
Journal:  Int J Biol Sci       Date:  2022-08-15       Impact factor: 10.750

7.  Clinical Value of Circulating ZFAS1 and miR-590-3p in the Diagnosis and Prognosis of Chronic Heart Failure.

Authors:  Guannan Chang; Wenqing Zhang; Meicheng Zhang; Gang Ding
Journal:  Cardiovasc Toxicol       Date:  2021-07-28       Impact factor: 3.231

8.  Efficacy of Shenmai injection for the treatment of chronic heart failure: A protocol of systematic review.

Authors:  Peng Gao; Xian Wu; Fu-Hua Zhang; Zhi-Li Qiao; Li-Jie Yang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

9.  Long noncoding RNA PVT1 contributes to vascular endothelial cell proliferation via inhibition of miR-190a-5p in diagnostic biomarker evaluation of chronic heart failure.

Authors:  Bin Sun; Meng Meng; Jiali Wei; Shuguang Wang
Journal:  Exp Ther Med       Date:  2020-03-12       Impact factor: 2.447

10.  Effect of grelin on TRX expression in chronic heart failure tissue: A protocol of systematic review and meta-analysis.

Authors:  Zhe Chen; Yao Feng; Ru-Bing Zhang; Xin Li; Jian-Bo Xu
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.